A phase-IV randomised, double blind comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliomyelitis Vaccine (mOPV1) versus trivalent OPV (tOPV): four-armed study

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2007
This article has no abstract
Epistemonikos ID: 3b926dfacd392d54ec06c0d1985a3545687d6a3b
First added on: Jan 17, 2025